Johnson & Johnson has committed $200-million dollars US to speed up its vaccine program to protect people from the deadly Ebola virus. They hope to produce a million doses by 2015. They will be safety testing in January on two potential Ebola vaccines. The two vaccines are delivered months apart, and have proved to work on monkeys in preventing the virus.